Preliminary clinical studies with ibenzmethyzin.
D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000009:adverse effects*; D001259:Ataxia / Q000209:etiology; D006801:Humans; D006834:Hydrazines / Q000009:adverse effects*; D009325:Nausea / Q000209:etiology; D009369:Neoplasms / Q000188:drug therapy*; D014717:Vertigo / Q000209:etiology; D014839:Vomiting / Q000209:etiology
D000970:Antineoplastic Agents; D006834:Hydrazines